Clinical efficacy assessment of new Baitouweng decoction in the treatment of active ulcerative colitis
-
摘要: 目的:观察新加白头翁汤联合西药对比单用西药治疗溃疡性结肠炎(UC)的临床疗效。方法:采用前瞻性队列研究。纳入活动期UC患者50例,对照组24例,试验组26例。试验组予新加白头翁汤联合西药治疗,对照组单用西药治疗,观察临床疗效。结果:与对照组比较,试验组临床缓解率69.2%高于对照组37.5%(P<0.05);临床有效率84.6%高于对照组58.3%(P<0.05),试验组黏膜愈合率为46.2%,对照组29.1%,2组差异无统计学意义。在症状改善方面,试验组对腹痛和黏液脓血便症状改善更好(P<0.05),但在腹泻症状改善方面2组差异无统计学意义(P>0.05)。在理化指标方面,治疗后试验组血沉(ESR)和粪钙卫蛋白(FCP)显著低于对照组(P<0.05,P<0.01),但治疗后2组C反应蛋白(CRP)比较,差异无统计学意义(P>0.05)。治疗过程中2组患者均未发现明显不良反应,安全性较好。结论:新加白头翁汤联合西药治疗UC时可起到明显的增效作用。Abstract: Objective: To observe the clinical efficacy of new Baitouweng decoction combined with Western medicine in the treatment of ulcerative colitis(UC).Methods: A prospective cohort study was conducted. Fifty patients with active UC, 24 in the control group and 26 in the experimental group were included. The experimental group was treated with new Baitouweng decoction combined with Western medicine, while the control group was treated with Western medicine alone.Results: Compared with the control group, the clinical remission rate of the experimental group was 69.2%, which was higher than 37.5% of the control group(P<0.05); The clinical effective rate of 84.6% was higher than 58.3% of the control group(P<0.05); The mucosal healing rate of the experimental group was 46.2%, which was 29.1% of the control group. In terms of symptom improvement, the experimental group had better improvement on abdominal pain and bloody mucus(P<0.05), but there was no significant difference in the improvement of diarrhea(P>0.05). In terms of physical and chemical indexes, ESR and FCP in the experimental group were significantly lower than those in the control group after treatment(P<0.05, P<0.01), but there was no significant difference in CRP between the two groups after treatment(P>0.05). During the treatment, no obvious adverse reactions were found in the two groups, and the safety was good.Conclusion: New Baitouweng decoction combined with western medicine can play a significant synergistic effect in the treatment of UC.
-
Key words:
- new Baitouweng decoction /
- ulcerative colitis /
- clinical efficacy
-
-
[1] 中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见(2018年·北京)[J].中国实用内科杂志,2018,38(9):796-813.
[2] Harbord M,Eliakim R,Bettenworth D,et al.Third European evidence-basedconsensus on diagnosis and management of ulcerativecolitis.Part 2:current management[J].J Crohns Colitis1,11(7):769-784.
[3] 沈洪,朱磊.重视溃疡性结肠炎的中西医结合治疗[J].中国中西医结合消化杂志,2016,24(8):571-574.
[4] 王新月,王建云.溃疡性结肠炎中医药治疗的关键问题与优势对策[J].中华中医药杂志,2012,27(2):263-267.
[5] 缪志伟,叶柏.从瘀毒论治溃疡性结肠炎临证心得[J].江苏中医药,2019,51(11):44-46.
[6] 中华中医药学会脾胃病分会.溃疡性结肠炎中医诊疗专家共识意见(2017)[J].中华中医药杂志,2017,32(8):3585-3589.
[7] 郑筱萸.中药新药临床指导原则[M].北京:中国医药科技出版社,2002.
[8] 周仲瑛.中医内科学[M].北京:中国中医药出版社,2007.
[9] 李军祥,陈誩.溃疡性结肠炎中西医结合诊疗共识意见(2017年)[J].中国中西医结合消化杂志,2018,26(2):105-111.
[10] 李鹏帆,罗月,顾思臻,等.基于网络药理学探讨白头翁汤治疗溃疡性结肠炎的作用机制[J].中国中西医结合消化杂志,2020,28(7):527-533.
-
计量
- 文章访问数: 357
- PDF下载数: 128
- 施引文献: 0
下载: